Back
LENZ Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
LENZ
LENZ Therapeutics
Last Price:
$25.63
Seasonality Move:
-9.34%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and LENZ is experiencing selling pressure, which indicates risk of future bearish movement.
LENZ Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.21 | Sell |
| 20-day SMA: | 24.49 | Buy |
| 50-day SMA: | 24.46 | Buy |
| 200-day SMA: | 25.18 | Buy |
| 8-day EMA: | 25.88 | Sell |
| 20-day EMA: | 25.15 | Buy |
| 50-day EMA: | 25.37 | Buy |
| 200-day EMA: | 25.05 | Buy |
LENZ Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 54.15 | Buy |
| Chaikin Money Flow: | -122533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.31 - 25.93) | Buy |
| Bollinger Bands (100): | (23.54 - 32.94) | Sell |
LENZ Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for LENZ Therapeutics Stock
Is LENZ Therapeutics Stock a Buy?
-
LENZ Therapeutics share price is 25.64 while LENZ 8-day simple moving average is 26.21, which is a Sell signal.
-
The stock price of LENZ is 25.64 while LENZ Therapeutics 20-day SMA is 24.49, which makes it a Buy.
-
LENZ Therapeutics 50-day simple moving average is 24.46 while LENZ share price is 25.64, making it a Buy technically.
-
LENZ stock price is 25.64 and LENZ Therapeutics 200-day simple moving average is 25.18, creating a Buy signal.
LENZ Technical Analysis vs Fundamental Analysis
Buy
55
LENZ Therapeutics (LENZ)
is a Buy
Is LENZ Therapeutics a Buy or a Sell?
-
LENZ Therapeutics stock is rated a BuyThe current LENZ Therapeutics [LENZ] share price is $25.64. The Score for LENZ is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
LENZ Therapeutics Stock Info
Market Cap:
706.2M
Price in USD:
25.64
Share Volume:
148.6K
LENZ Therapeutics 52-Week Range
52-Week High:
38.93
52-Week Low:
14.42
Buy
55
LENZ Therapeutics (LENZ)
is a Buy
LENZ Therapeutics Share Price Forecast
-
What is the LENZ Therapeutics stock price today?The LENZ Therapeutics stock price is 25.64 USD today.
-
Will LENZ stock go up or go down?LENZ Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is LENZ Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, LENZ Therapeutics is not overvalued.
Is LENZ Therapeutics Stock a Buy?
-
LENZ Therapeutics share price is 25.64 while LENZ 8-day exponential moving average is 25.88, which is a Sell signal.
-
The stock price of LENZ is 25.64 while LENZ Therapeutics 20-day EMA is 25.15, which makes it a Buy.
-
LENZ Therapeutics 50-day exponential moving average is 25.37 while LENZ share price is 25.64, making it a Buy technically.
-
LENZ stock price is 25.64 and LENZ Therapeutics 200-day simple moving average is 25.05, creating a Buy signal.
Fundamental Analysis of LENZ Therapeutics
Is LENZ Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and an increase next year of $0.02 per share.
Technical Analysis of LENZ Therapeutics
Should I short LENZ Therapeutics stock?
-
LENZ Moving Average Covergence Divergence (MACD) indicator is 0.54, suggesting LENZ Therapeutics is a Buy
-
LENZ Therapeutics Relative Strength Index (RSI) is 54.15, which suggest LENZ Therapeutics is overbought
-
The Bollinger Bands (25) for LENZ Therapeutics is (22.31 - 25.93), which suggest LENZ Therapeutics is a Sell
-
The Bollinger Bands (100) for LENZ Therapeutics is (23.54 - 32.94), which suggest LENZ Therapeutics is a Sell
* LENZ Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.